Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical and microbial efficacy of ISV-403 administered three times a day
(TID) for 5 days compared to vehicle three times a day for 5 days in the treatment of
bacterial conjunctivitis